company background image
3613 logo

Beijing Tong Ren Tang Chinese Medicine SEHK:3613 株式レポート

最終価格

HK$8.60

時価総額

HK$7.2b

7D

13.3%

1Y

-33.6%

更新

27 Sep, 2024

データ

会社財務 +

Beijing Tong Ren Tang Chinese Medicine Company Limited

SEHK:3613 株式レポート

時価総額:HK$7.2b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

3613 株式概要

北京同仁堂中医薬有限公司は、その子会社とともに、卸売業者や個人向けにヘルスケア製品や漢方薬の製造、小売、卸売を行っている。

3613 ファンダメンタル分析
スノーフレーク・スコア
評価1/6
将来の成長3/6
過去の実績1/6
財務の健全性5/6
配当金4/6

Beijing Tong Ren Tang Chinese Medicine Company Limited 競合他社

価格と性能

の歴代最高値、変動、値下がりまとめBeijing Tong Ren Tang Chinese Medicine
過去の株価
現在の株価HK$8.60
52週高値HK$13.44
52週安値HK$7.03
ベータ0.41
11ヶ月の変化2.63%
3ヶ月変化-4.55%
1年変化-33.64%
33年間の変化-15.85%
5年間の変化-25.86%
IPOからの変化31.70%

最新ニュース

Earnings Troubles May Signal Larger Issues for Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Shareholders

Sep 06
Earnings Troubles May Signal Larger Issues for Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Shareholders

Is There An Opportunity With Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 31% Undervaluation?

Sep 02
Is There An Opportunity With Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 31% Undervaluation?

Recent updates

Earnings Troubles May Signal Larger Issues for Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Shareholders

Sep 06
Earnings Troubles May Signal Larger Issues for Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Shareholders

Is There An Opportunity With Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 31% Undervaluation?

Sep 02
Is There An Opportunity With Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 31% Undervaluation?

Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 28% Share Price Plunge Could Signal Some Risk

Feb 05
Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 28% Share Price Plunge Could Signal Some Risk

Calculating The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

Jan 03
Calculating The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

A Look At The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

Sep 28
A Look At The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

Here's Why We Think Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Might Deserve Your Attention Today

Jul 12
Here's Why We Think Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Might Deserve Your Attention Today

Is Now The Time To Put Beijing Tong Ren Tang Chinese Medicine (HKG:3613) On Your Watchlist?

Mar 29
Is Now The Time To Put Beijing Tong Ren Tang Chinese Medicine (HKG:3613) On Your Watchlist?

Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Has Announced That It Will Be Increasing Its Dividend To HK$0.28

Apr 28
Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Has Announced That It Will Be Increasing Its Dividend To HK$0.28

Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Will Pay A Larger Dividend Than Last Year At HK$0.28

Mar 25
Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Will Pay A Larger Dividend Than Last Year At HK$0.28

Are Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Investors Paying Above The Intrinsic Value?

Oct 27
Are Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Investors Paying Above The Intrinsic Value?

Beijing Tong Ren Tang Chinese Medicine's (HKG:3613) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 28
Beijing Tong Ren Tang Chinese Medicine's (HKG:3613) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares

Mar 11
Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares

What Type Of Returns Would Beijing Tong Ren Tang Chinese Medicine's(HKG:3613) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Feb 04
What Type Of Returns Would Beijing Tong Ren Tang Chinese Medicine's(HKG:3613) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Should Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Be Part Of Your Dividend Portfolio?

Jan 18
Should Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Be Part Of Your Dividend Portfolio?

Could The Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Ownership Structure Tell Us Something Useful?

Dec 29
Could The Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Ownership Structure Tell Us Something Useful?

Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares

Dec 11
Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares

Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Nov 23
Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

株主還元

3613HK PharmaceuticalsHK 市場
7D13.3%6.1%9.8%
1Y-33.6%13.7%12.9%

業界別リターン: 3613過去 1 年間で11.7 % の収益を上げたHong Kong Pharmaceuticals業界を下回りました。

リターン対市場: 3613は、過去 1 年間で4.6 % のリターンを上げたHong Kong市場を下回りました。

価格変動

Is 3613's price volatile compared to industry and market?
3613 volatility
3613 Average Weekly Movement4.9%
Pharmaceuticals Industry Average Movement4.6%
Market Average Movement6.6%
10% most volatile stocks in HK Market13.6%
10% least volatile stocks in HK Market3.5%

安定した株価: 3613過去 3 か月間に大きな価格変動はありませんでした。

時間の経過による変動: 3613の 週次ボラティリティ ( 4% ) は過去 1 年間安定しています。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
1669779Wang Chiwww.tongrentangcm.com

北京同仁堂中医薬有限公司は、その子会社とともに、卸売業者や個人向けにヘルスケア製品や漢方薬の製造、小売、卸売を行っている。同社は3つのセグメントで事業を展開している:香港、中国本土、海外。また、漢方相談や治療サービスも提供している。香港をはじめ、アジア、オセアニア、北米、ヨーロッパの国や地域で小売店を展開している。製品は「同仁堂」ブランドで販売している。北京同仁堂中医薬有限公司は1669年に設立され、香港の湾仔に本社を置いている。

Beijing Tong Ren Tang Chinese Medicine Company Limited 基礎のまとめ

Beijing Tong Ren Tang Chinese Medicine の収益と売上を時価総額と比較するとどうか。
3613 基礎統計学
時価総額HK$7.20b
収益(TTM)HK$494.14m
売上高(TTM)HK$1.38b

14.6x

PER(株価収益率

5.2x

P/Sレシオ

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
3613 損益計算書(TTM)
収益HK$1.38b
売上原価HK$384.69m
売上総利益HK$991.96m
その他の費用HK$497.83m
収益HK$494.14m

直近の収益報告

Jun 30, 2024

次回決算日

該当なし

一株当たり利益(EPS)0.59
グロス・マージン72.06%
純利益率35.89%
有利子負債/自己資本比率0.006%

3613 の長期的なパフォーマンスは?

過去の実績と比較を見る

配当金

3.8%

現在の配当利回り

56%

配当性向